The double-blind controlled trial of bupropion and amitriptyline in the treatment of 229 patients with depressive disorders

被引：0
|
作者：
Wang, Chuanyue
Zhang, Hongyan
Gao, Chengge
Zhang, Xiuping
Cao, Yi
机构：
[1] Capital Univ Med Sci, Beijing Anding Hosp, Beijing, Peoples R China
[2] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China
[3] Xian Jiaotong Univ, Hosp 1, Xian 710049, Peoples R China
[4] Shandong Mental Hlth Ctr, Shandong, Peoples R China
[5] Tianjin Anding Hosp, Tianjin, Peoples R China
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
bupropion; amitriptyline; depressive disorders;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [31] THE EFFICACY AND SAFETY OF TIANEPTINE IN THE TREATMENT OF DEPRESSIVE DISORDER - RESULTS OF A CONTROLLED DOUBLE-BLIND MULTICENTER STUDY VS AMITRIPTYLINE
    INVERNIZZI, G
    AGUGLIA, E
    BERTOLINO, A
    CASACCHIA, M
    CIANI, N
    MARCHESI, GF
    NARDINI, M
    RAPISARDA, V
    NEUROPSYCHOBIOLOGY, 1994, 30 (2-3) : 85 - 93
  • [32] FLUVOXAMINE AND IMIPRAMINE IN THE TREATMENT OF DEPRESSIVE PATIENTS - A DOUBLE-BLIND CONTROLLED-STUDY
    GONELLA, G
    BAIGNOLI, G
    ECARI, U
    CURRENT MEDICAL RESEARCH AND OPINION, 1990, 12 (03) : 177 - 184
  • [33] Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial
    Tabuteau, Herriot
    Jones, Amanda
    Anderson, Ashley
    Jacobson, Mark
    Iosifescu, Dan, V
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (07): : 490 - 499
  • [34] TREATMENT OF SECONDARY DEPRESSION IN SCHIZOPHRENIA - DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF AMITRIPTYLINE ADDED TO PERPHENAZINE
    PRUSOFF, BA
    WILLIAMS, DH
    WEISSMAN, MM
    ASTRACHAN, BM
    ARCHIVES OF GENERAL PSYCHIATRY, 1979, 36 (05) : 569 - 575
  • [35] Rosemary as an adjunctive treatment in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Azizi, Saeed
    Mohamadi, Neda
    Sharififar, Fariba
    Dehghannoudeh, Gholamreza
    Jahanbakhsh, Farzaneh
    Dabaghzadeh, Fatemeh
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2022, 49
  • [36] CLOVOXAMINE AND DOXEPIN IN MAJOR DEPRESSIVE DISORDER - A DOUBLE-BLIND CONTROLLED TRIAL
    LODGE, GJ
    FREEMAN, HL
    BRITISH JOURNAL OF PSYCHIATRY, 1986, 148 : 718 - 721
  • [37] A DOUBLE-BLIND PLACEBO-CONTROLLED COMPARISON OF MOCLOBEMIDE AND AMITRIPTYLINE IN THE TREATMENT OF DEPRESSION
    BAKISH, D
    WIENS, A
    ELLIS, J
    ALDA, M
    LAPIERRE, Y
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1992, 37 (07): : 12 - 17
  • [38] Tetrahydrobiopterin as a Treatment for Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled Trial
    Klaiman, Cheryl
    Huffman, Lynne
    Masaki, Lauren
    Elliott, Glen R.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (05) : 320 - 328
  • [39] DOUBLE-BLIND, CONTROLLED TRIAL OF INOSITOL TREATMENT OF DEPRESSION
    LEVINE, J
    BARAK, Y
    GONZALVES, M
    SZOR, H
    ELIZUR, A
    KOFMAN, O
    BELMAKER, RH
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (05): : 792 - 794
  • [40] A DOUBLE-BLIND EVALUATION OF ZIMELIDINE IN COMPARISON TO PLACEBO AND AMITRIPTYLINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    CLAGHORN, J
    GERSHON, S
    GOLDSTEIN, BJ
    BEHRNETZ, S
    BUSH, DF
    HUITFELDT, B
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1983, 7 (2-3): : 367 - 382
12345